Drawray

Website

Drawray Technological innovation brings life care all around

23/10/2026

We are pleased to share that our distributor participated in the 4th International Congress of Endocrinologists of Uzbekistan – Turakulov Readings 2026, an international event bringing together specialists in endocrinology and laboratory diagnostics.

At the event, our distributor showcased the Drawray iStar 500 Mono-test CLIA Analyzer, highlighting its applications in diabetes-related testing.

🧬 Featured Tests for Diabetes Assessment

Insulin & C-Peptide — Assessment of insulin secretion and pancreatic β-cell function.
ZnT8A, GADA, IA-2A, ICA & IAA — Supporting the assessment of islet autoimmunity and diabetes classification.

With its flexible mono-test design, the iStar 500 enables laboratories to select and combine assays according to their testing needs, supporting a more comprehensive approach to diabetes-related laboratory assessment.

We are proud to see our diagnostic solutions featured at professional scientific events and look forward to continued collaboration with our partners in advancing laboratory diagnostics.

🦴 World Osteoporosis Day | October 20Strong bones are essential to lifelong health. Osteoporosis often progresses silent...
20/10/2026

🦴 World Osteoporosis Day | October 20

Strong bones are essential to lifelong health. Osteoporosis often progresses silently, making awareness, early assessment, and
ongoing bone health management important at every stage of life.

Laboratory testing can help assess bone metabolism and support the evaluation of factors affecting bone health.

Drawray Bone Metabolism Test Panel
🔹25-OH Vitamin D — Assessment of vitamin D status
🔹PTH — Evaluation of calcium regulation
🔹Calcitonin — Involved in calcium regulation and bone metabolism

This World Osteoporosis Day, let's raise awareness of bone health and encourage informed conversations about prevention, assessment, and care.

Meet Drawray at MEDICA 2026!Innovation in diagnostics moves forward through collaboration, shared expertise, and a commo...
15/10/2026

Meet Drawray at MEDICA 2026!

Innovation in diagnostics moves forward through collaboration, shared expertise, and a common commitment to better healthcare.

At MEDICA 2026, Drawray looks forward to reconnecting with global partners, meeting industry professionals, and exploring opportunities to advance IVD solutions across diverse clinical settings.

📅 November 16–19, 2026
📍 Messe Düsseldorf, Germany
📌 Booth No.: 1D15

Let’s exchange ideas and build new possibilities together. See you in Düsseldorf!

World Arthritis Day | October 12 💙Early detection plays a key role in effective rheumatoid arthritis (RA) management.Dra...
12/10/2026

World Arthritis Day | October 12 💙

Early detection plays a key role in effective rheumatoid arthritis (RA) management.

Drawray Test Panel with RF, Anti-CCP, and CRP supports the early detection and effective management of rheumatoid arthritis (RA), helping healthcare professionals make informed clinical decisions.

Together, let’s raise awareness and promote the importance of early assessment for better patient care.

09/10/2026

Connecting Cardiology. Advancing Diagnostics.

Drawray iStar 500 Mono-test CLIA was recently showcased by our local partner at the international scientific-practical conference “Modern Cardiology: From Prevention to High Technologies,” held in Tashkent, Uzbekistan, on October 2–3, 2026.

Bringing together cardiology experts and healthcare professionals from Uzbekistan and Turkic-speaking countries, the conference provided a valuable platform for scientific exchange, clinical insights, and discussions on the latest advances in cardiovascular care.

Against this backdrop of academic collaboration and medical innovation, the presentation of iStar 500 highlighted Drawray’s commitment to advancing cardiac diagnostics. With its innovative mono-test CLIA platform, whole blood testing capability, and rapid turnaround time, iStar 500 supports efficient cardiac biomarker testing and helps deliver timely diagnostic information for clinical decision-making.

We remain committed to advancing cardiovascular diagnostics through innovation and collaboration, delivering practical solutions that support healthcare professionals worldwide.

🇨🇳Happy National Day!Celebrating innovation, progress, and a brighter future.Drawray wishes everyone a joyful National D...
01/10/2026

🇨🇳Happy National Day!

Celebrating innovation, progress, and a brighter future.

Drawray wishes everyone a joyful National Day!

World Heart Day | Every Heart MattersEarly detection provides valuable insights for better cardiovascular care.On World ...
29/09/2026

World Heart Day | Every Heart Matters

Early detection provides valuable insights for better cardiovascular care.

On World Heart Day, Drawray highlights the Cardiac Biomarker Solution, offering a comprehensive portfolio of biomarkers including:
cTnI • hs-cTnI • cTnT • hs-cTnT • Myo • CK-MB • D-Dimer • NT-proBNP • sST2

Supporting cardiovascular assessment with advanced diagnostic solutions for healthcare professionals worldwide.

🥮 Happy Mid-Autumn Festival!As the full moon shines bright, may it bring you and your loved ones happiness, harmony, and...
25/09/2026

🥮 Happy Mid-Autumn Festival!

As the full moon shines bright, may it bring you and your loved ones happiness, harmony, and cherished moments together.

Wishing you a joyful and meaningful celebration!

Why Does HbA1c Testing Matter?HbA1c provides a view of average glycemic levels over approximately 2–3 months, making it ...
23/09/2026

Why Does HbA1c Testing Matter?

HbA1c provides a view of average glycemic levels over approximately 2–3 months, making it an important biomarker for assessing glycemic status and monitoring diabetes management. It is also used for diabetes screening and diagnosis when appropriate.

Bringing practical HbA1c testing to routine care

The Drawray Unicorn HbA1c Fluorescence Assay combines rapid testing with a small sample requirement and robust analytical performance, supporting efficient HbA1c testing in routine clinical settings.

From sample collection to result, every step is designed with simplicity and efficiency in mind — helping laboratories and healthcare professionals streamline daily testing.

Understanding NT-proBNP: A Valuable Biomarker for Heart Failure AssessmentNT-proBNP is a valuable cardiac biomarker rele...
17/09/2026

Understanding NT-proBNP: A Valuable Biomarker for Heart Failure Assessment

NT-proBNP is a valuable cardiac biomarker released in response to increased myocardial wall stress, providing important information to support the evaluation of patients with suspected heart failure.

Clinical Applications of NT-proBNP：
🔹 Diagnosis Support & HF Rule-Out
🔹 Risk Stratification & Prognostic Assessment

With Drawray NT-proBNP, rapid and reliable testing supports efficient heart failure assessment.

Sample Types: Whole Blood, Serum and Plasma

Fast testing. Reliable results. Supporting better heart failure assessment.

Address

Room 301, Kingsignal Building 1, No. 50, Baolong 2nd Road, Baolong Subdistrict, Longgang District
Shenzhen
518000

Website

Alerts

Be the first to know and let us send you an email when Drawray posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category